{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:47:42Z","timestamp":1793828862961,"version":"4.6.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04239-6","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T12:05:44Z","timestamp":1756728344000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Ulinastatin for the treatment of severe acute pancreatitis: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Sanjay","family":"Bandyopadhyay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shambo Samrat","family":"Samajdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saibal","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"issue":"11","key":"4239_CR1","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1136\/gutjnl-2016-313595","volume":"66","author":"SM Van DIjk","year":"2017","unstructured":"Van DIjk SM, Hallensleben ND, van Santvoort HC, Fockens P, van Goor H, Bruno MJ, Besselink MG. Acute pancreatitis: recent advances through randomised trials. Gut. 2017;66(11):2024\u201332.","journal-title":"Gut"},{"issue":"5","key":"4239_CR2","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.3390\/nu13051498","volume":"13","author":"B Jab\u0142o\u0144ska","year":"2021","unstructured":"Jab\u0142o\u0144ska B, Mrowiec S. Nutritional support in patients with severe acute pancreatitis-current standards. Nutrients. 2021;13(5):1498.","journal-title":"Nutrients"},{"issue":"8","key":"4239_CR3","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1007\/s11739-024-03666-9","volume":"19","author":"D Padula","year":"2024","unstructured":"Padula D, Mauro A, Maggioni P, Kurihara H, Di Sabatino A, Anderloni A. Practical approach to acute pancreatitis: from diagnosis to the management of complications. Intern Emerg Med. 2024;19(8):2091\u2013104.","journal-title":"Intern Emerg Med"},{"issue":"4","key":"4239_CR4","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.pan.2013.07.063","volume":"13","author":"AA Guidelines","year":"2013","unstructured":"Guidelines AA. IAP\/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology. 2013;13(4):e1\u20135.","journal-title":"Pancreatology"},{"issue":"3","key":"4239_CR5","doi-asserted-by":"publisher","first-page":"419","DOI":"10.14309\/ajg.0000000000002645","volume":"119","author":"S Tenner","year":"2024","unstructured":"Tenner S, Vege SS, Sheth SG, Sauer B, Yang A, Conwell DL, Yadlapati RH, Gardner TB. American college of gastroenterology guidelines: management of acute pancreatitis. Official J Am Coll Gastroenterology| ACG. 2024;119(3):419\u201337.","journal-title":"Official J Am Coll Gastroenterology| ACG"},{"key":"4239_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13017-019-0247-0","volume":"14","author":"A Lepp\u00e4niemi","year":"2019","unstructured":"Lepp\u00e4niemi A, Tolonen M, Tarasconi A, Segovia-Lohse H, Gamberini E, Kirkpatrick AW, Ball CG, Parry N, Sartelli M, Wolbrink D, Van Goor H. 2019 WSES guidelines for the management of severe acute pancreatitis. World J Emerg Surg. 2019;14:1\u201320.","journal-title":"World J Emerg Surg"},{"issue":"5","key":"4239_CR7","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1097\/01.CCM.0000215110.55899.AE","volume":"34","author":"K Nakanishi","year":"2006","unstructured":"Nakanishi K, Takeda S, Sakamoto A, Kitamura A. Effects of Ulinastatin treatment on the cardiopulmonary bypass-induced hemodynamic instability and pulmonary dysfunction. Crit Care Med. 2006;34(5):1351\u20137.","journal-title":"Crit Care Med"},{"key":"4239_CR8","unstructured":"Prescribing information. Ulinastatin for Injection. Available from: https:\/\/bsvgroup.com\/assets\/pdf\/products\/U-Tryp(Liquid).pdf. Accessed on January 20, 2025."},{"issue":"3","key":"4239_CR9","doi-asserted-by":"publisher","first-page":"73037","DOI":"10.21037\/apm.2020.04.19","volume":"9","author":"HW He","year":"2020","unstructured":"He HW, Zhang H. The efficacy of different doses of Ulinastatin in the treatment of severe acute pancreatitis. Annals Palliat Med. 2020;9(3):73037\u2013737.","journal-title":"Annals Palliat Med"},{"issue":"2","key":"4239_CR10","first-page":"918","volume":"14","author":"L Zhao","year":"2022","unstructured":"Zhao L, Ma Y, Li Q, Wang Y. Ulinastatin combined with glutamine improves liver function and inflammatory response in patients with severe acute pancreatitis. Am J Translational Res. 2022;14(2):918.","journal-title":"Am J Translational Res"},{"issue":"1","key":"4239_CR11","doi-asserted-by":"publisher","first-page":"e370108","DOI":"10.1590\/acb370108","volume":"37","author":"X Feng","year":"2022","unstructured":"Feng X, Ma W, Chen J, Jiao W, Wang Y. Ulinastatin alleviates early brain injury after traumatic brain injury by inhibiting oxidative stress and apoptosis. Acta Cirurgica Brasileira. 2022;37(1):e370108.","journal-title":"Acta Cirurgica Brasileira"},{"key":"4239_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-016-1207-7","volume":"20","author":"X Wan","year":"2016","unstructured":"Wan X, Xie X, Gendoo Y, Chen X, Ji X, Cao C. Ulinastatin administration is associated with a lower incidence of acute kidney injury after cardiac surgery: a propensity score matched study. Crit Care. 2016;20:1\u20137.","journal-title":"Crit Care"},{"issue":"1","key":"4239_CR13","first-page":"630835","volume":"2014","author":"QL He","year":"2014","unstructured":"He QL, Zhong F, Ye F, Wei M, Liu WF, Li MN, Li QB, Huang WQ, Sun LB, Shu HH. Does intraoperative Ulinastatin improve postoperative clinical outcomes in patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials. Biomed Res Int. 2014;2014(1):630835.","journal-title":"Biomed Res Int"},{"key":"4239_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12890-019-0968-6","volume":"19","author":"X Zhang","year":"2019","unstructured":"Zhang X, Zhu Z, Jiao W, Liu W, Liu F, Zhu X. Ulinastatin treatment for acute respiratory distress syndrome in china: a meta-analysis of randomized controlled trials. BMC Pulm Med. 2019;19:1\u20139.","journal-title":"BMC Pulm Med"},{"key":"4239_CR15","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"4239_CR16","unstructured":"Ottawa Hospital Research Institute. Available from: https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. Cited 2025 Jun 30."},{"issue":"4","key":"4239_CR17","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383\u201394.","journal-title":"J Clin Epidemiol"},{"issue":"7650","key":"4239_CR18","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924\u20136.","journal-title":"BMJ"},{"issue":"8","key":"4239_CR19","first-page":"535","volume":"61","author":"P Abraham","year":"2013","unstructured":"Abraham P, Rodriques J, Moulick N, Dharap S, Chafekar N, Verma PK, Agrawal A, Prabhakar B, Basavaraj A, Shah A, Chaphekar AP. Efficacy and safety of intravenous Ulinastatin versus placebo along with standard supportive care in subjects with mild or severe acute pancreatitis. J Assoc Phys India. 2013;61(8):535\u20138.","journal-title":"J Assoc Phys India"},{"issue":"5","key":"4239_CR20","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/MAJ.0b013e31827aa2bc","volume":"346","author":"G Wang","year":"2013","unstructured":"Wang G, Wen J, Wen P, Wilbur RR, Zhou SF, Xiao X. The effect of somatostatin, Ulinastatin and salvia miltiorrhiza on severe acute pancreatitis treatment. Am J Med Sci. 2013;346(5):371\u20136.","journal-title":"Am J Med Sci"},{"issue":"5","key":"4239_CR21","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.amjms.2016.03.013","volume":"351","author":"G Wang","year":"2016","unstructured":"Wang G, Liu Y, Zhou SF, Qiu P, Xu L, Wen P, Wen J, Xiao X. Effect of somatostatin, Ulinastatin and gabexate on the treatment of severe acute pancreatitis. Am J Med Sci. 2016;351(5):506\u201312.","journal-title":"Am J Med Sci"},{"issue":"16","key":"4239_CR22","first-page":"1252","volume":"97","author":"J Wang","year":"2017","unstructured":"Wang J, Jin J, Huang J, Li DR, Hao Y, Kong JD, Chu ZY, Fu JH, Huang F. Clinical value of the early use of Ulinastatin in patients with moderately severe or severe acute pancreatitis. Zhonghua Yi Xue Za Zhi. 2017;97(16):1252\u20135.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"4239_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jcrc.2018.01.021","volume":"45","author":"JY Lagoo","year":"2018","unstructured":"Lagoo JY, D\u2019Souza MC, Kartha A, Kutappa AM. Role of ulinastatin, a trypsin inhibitor, in severe acute pancreatitis in critical care setting: A retrospective analysis. J Crit Care. 2018;45:27\u201332.","journal-title":"J Crit Care"},{"issue":"1","key":"4239_CR24","doi-asserted-by":"publisher","first-page":"90","DOI":"10.29271\/jcpsp.2019.01.90","volume":"29","author":"L Meng","year":"2019","unstructured":"Meng L, Wu Z, Zhang H. Effect of Ulinastatin combined with octreotide on serum endothelin, endotoxin levels and immune function in acute pancreatitis. J Coll Physicians Surg Pak. 2019;29(1):90\u20132.","journal-title":"J Coll Physicians Surg Pak"},{"issue":"19","key":"4239_CR25","doi-asserted-by":"publisher","first-page":"4601","DOI":"10.12998\/wjcc.v11.i19.4601","volume":"11","author":"SQ Wang","year":"2023","unstructured":"Wang SQ, Jiao W, Zhang J, Zhang JF, Tao YN, Jiang Q, Yu F. Ulinastatin in the treatment of severe acute pancreatitis: A single-center randomized controlled trial. World J Clin Cases. 2023;11(19):4601.","journal-title":"World J Clin Cases"},{"issue":"9","key":"4239_CR26","first-page":"5797","volume":"15","author":"F Chen","year":"2023","unstructured":"Chen F, Xu Y, Wang Z. Ulinastatin combined with somatostatin enhances disease control and modulates serum inflammatory factors in patients with severe pancreatitis. Am J Translational Res. 2023;15(9):5797.","journal-title":"Am J Translational Res"},{"issue":"8","key":"4239_CR27","first-page":"1729","volume":"40","author":"H Dou","year":"2024","unstructured":"Dou H, Kan Y, Xu Z, Wang Z, Zheng C. Effect of probiotics combined with Ulinastatin and somatostatin in the treatment of severe acute pancreatitis. Pakistan J Med Sci. 2024;40(8):1729.","journal-title":"Pakistan J Med Sci"},{"key":"4239_CR28","unstructured":"Yang X, Li Y, Han F. Effect of Ulinastatin combined with somatostatin on inflammatory markers, hemodynamics and immune cells in the treatment of severe pancreatitis. Altern Ther Health Med. 2024:AT10234."},{"issue":"7","key":"4239_CR29","first-page":"8067","volume":"13","author":"Q Zhu","year":"2021","unstructured":"Zhu Q, Zou F, Lin J, Liu X, Luo Y. Effect of continuous renal replacement therapy adjuvant to broad-spectrum enzyme inhibitors on the efficacy and inflammatory cytokines in patients with severe acute pancreatitis. Am J Translational Res. 2021;13(7):8067.","journal-title":"Am J Translational Res"},{"issue":"1","key":"4239_CR30","doi-asserted-by":"publisher","first-page":"17979","DOI":"10.1038\/s41598-022-22341-7","volume":"12","author":"IL Horv\u00e1th","year":"2022","unstructured":"Horv\u00e1th IL, Bunduc S, Feh\u00e9rv\u00e1ri P, V\u00e1ncsa S, Nagy R, Garmaa G, Kleiner D, Hegyi P, Er\u0151ss B, Csupor D. The combination of Ulinastatin and somatostatin reduces complication rates in acute pancreatitis: a systematic review and meta-analysis of randomized controlled trials. Sci Rep. 2022;12(1):17979.","journal-title":"Sci Rep"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04239-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04239-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04239-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T01:59:17Z","timestamp":1757469557000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-04239-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4239"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04239-6","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"assertion":[{"value":"13 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"629"}}